AI CAN HELP DOCTORS FIGHT TUBERCULOSIS.

RADIFY® — Accelerating Diagnosis. Prioritising Care.

RADIFY® is an advanced AI-powered solution designed to assist radiologists in diagnosing more chest X-rays, with greater consistency and in less time — helping healthcare providers prioritise patients who need urgent care the most.

Why Chest X-Rays?

Chest X-rays remain the first-line imaging tool for pneumonia — a condition that is both fast-acting and deadly, especially for patients with tuberculosis (TB). They are accessible, quick, and cost-effective, making them critical in resource-limited settings.

What RADIFY® Detects

RADIFY® detects 16 key abnormalities on chest X-rays, including:

  • TB-associated patterns
  • Pneumonia-related opacities
  • Consolidations, infiltrates, and lymphadenopathy

It can process and prioritise over 2,000 images per minute, enabling rapid triage in both high-volume hospitals and remote point-of-care facilities.

Use Case 1: Elderly Patient with Suspected Pneumonia

Patient:

76-year-old male presenting with chest pain and shortness of breath.

Findings:

Patchy infiltrates in both upper zones and air space opacification in the mid and lower zones.

RADIFY® Output:

Bounding boxes highlight all regions of interest.

Diagnosis:

High probability of pneumonia.

How RADIFY® Helps Hospitals and Clinics

Triage During Overload

Prioritise the most critical cases during scan backlogs or surges.

Support Point-of-Care Diagnostics

Deploy with portable X-ray units to assess patients on-site, in real time.

Monitor Disease Progression

Track patients with mild or recurring symptoms to catch deterioration early.

RADIFY® for Tuberculosis

Tuberculosis is one of the world’s top 10 causes of death, and the leading infectious killer — above HIV/AIDS.

In 2019, TB claimed 1.4 million lives, including 208,000 people living with HIV.

An estimated 10 million fell ill, 1.2 million of whom were children.

In 2020, TB diagnoses dropped by 21% globally, leading to missed treatment opportunities — especially in South Africa, Indonesia, the Philippines, and India.

RADIFY® helps address this gap by:

Detecting TB-associated abnormalities on chest X-rays.

Triaging patients by high, intermediate, and low probability of TB.

Supporting radiologists in both public and private healthcare systems.

Use Case 2: Paediatric TB Detection

Patient:

10-year-old child with suspected TB.

Findings:

Bilateral lymphadenopathy and bi-basal confluent consolidation.

RADIFY® Output:

Regions of interest clearly highlighted.

Diagnosis:

High probability of tuberculosis.

Be part of the future of medical imaging

Fill in the form and a member of our team will get in touch to schedule a demo or answer your questions.

Contact us

+27 11 486 0692 / 0847

Info@envisionit.ai

South African Office

2nd Floor, One-on Jameson Building, 1 Jameson Avenue, Melrose Estate, Johannesburg, 2196

Welcome! We use cookies – Cookies tell us which parts of our websites you visited, help us measure the effectiveness of ads and web searches, and give us insights into user behaviour, so that we can improve our communications and products. Learn more about this in our Privacy Policy.

Welcome! We use cookies – Cookies tell us which parts of our websites you visited, help us measure the effectiveness of ads and web searches, and give us insights into user behaviour, so that we can improve our communications and products. Learn more about this in our Privacy Policy.